The cholinergic system in cyclophosphamide induced-Chagas dilated myocardiopathy in Trypanosoma cruzi infected rats: An electrocardiographic study

Investigacion Clinica

Volumn 49, Issue 2, 2008, Pages 207-224

  Labrador Hernández, Marialeycnan ^a   Suárez Graterol, Oscar ^a   Romero Contreras, Urimare ^a   Rumenoff, Lila ^a   Rodríguez Bonfante, Claudina ^a   Bonfante Cabarcas, Rafael ^a  

^a UNIVERSIDAD CENTROCCIDENTAL LISANDRO ALVARADO   (Venezuela)

Author keywords

Chagasic cardiomyopathy; Cyclophosphamide; Trypanosoma cruzi

Indexed keywords

4 DIPHENYLACETOXY 1 METHYLPIPERIDINE; CYCLOPHOSPHAMIDE; METHOCTRAMINE; PHENYLEPHRINE; TACRINE; TROPICAMIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRADYCARDIA; CELL PROLIFERATION; CHAGAS DISEASE; CHOLINERGIC SYSTEM; CONTROLLED STUDY; ELECTROCARDIOGRAPHY; HEART RATE; HISTOPATHOLOGY; NONHUMAN; PR INTERVAL; PRESSORECEPTOR REFLEX; QRS COMPLEX; QT INTERVAL; QT PROLONGATION; RADIOGRAPHY; RAT; T LYMPHOCYTE; TACHYCARDIA; TRYPANOSOMA CRUZI; TRYPOMASTIGOTE;

ACETYLCHOLINE; ANIMALS; AUTOIMMUNE DISEASES OF THE NERVOUS SYSTEM; BAROREFLEX; BRADYCARDIA; CD8-POSITIVE T-LYMPHOCYTES; CHAGAS CARDIOMYOPATHY; CYCLOPHOSPHAMIDE; DIAMINES; ELECTROCARDIOGRAPHY; MODELS, BIOLOGICAL; MUSCARINIC ANTAGONISTS; PHENYLEPHRINE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, MUSCARINIC; REFLEX, ABNORMAL; TACRINE; TROPICAMIDE; VAGUS NERVE; VASOCONSTRICTION;

EID: 49449096342     PISSN: 05355133     EISSN: 05355133     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Añez N, Crisante G, Rojas A, Díaz N, Añez-Rojas N, Carrasco H, Parada H, Aguilera M, Moreno G, Galíndez-Girón I, Sandoval R, Sandoval I, Vásquez L, Nava-Rulo O, Guerra F, Uzcátegui G, Yépez J, Rodriguez C, Bonfante-Cabarcas R. La cara oculta de la enfermedad de Chagas de Venezuela. Bol Malariol Salud Ambien 2003; 63:45-57.
2. Moncayo A, Ortiz-Yanine MI. An update on Chagas disease (human American trypanosomiasis). Ann Trop Med Parasitol 2006; 100: 663-677.
3. Davila DF, Donis JH, Torres A, Ferrer JA. A modified and unifying neurogenic hypothesis can explain the natural history of chronic Chagas heart disease. Int J Cardiol 2004; 96:191-195.
4. Junqueira Junior LF, Gallo Junior L, Manco JC, Marin-Neto JA, Amorim DS. Subtle cardiac autonomic impairment in Chagas' disease detected by baroreflex sensitivity testing. Braz J Med Biol Res 1985; 18:171-178.
5. Villar JC, Leon H, Morillo CA. Cardiovascular autonomic function testing in asymptomatic T. cruzi carriers: a sensitive method to identify subclinical Chagas' disease. Int J Cardiol 2004; 93:189-195.
6. Junqueira Junior LF, Beraldo PS, Chapadeiro E, Jesus PC. Cardiac autonomic dysfunction and neuroganglionitis in a rat model of chronic Chagas' disease. Cardiovasc Res 1992; 26:324-329.
7. Chapadeiro E, Florencio RF, Afonso PC, Beraldo PS, de Jesus PC, Junqueira Junior LF. Neuronal counting and parasympathetic dysfunction in the hearts of chronically Trypanosoma cruzi-infected rats. Rev Inst Med Trop Sao Paulo 1991; 33: 337-341.
8. Gurtu S, Sharma DK, Pant KK, Sinha JN, Bhargava KP. Role of medullary cholinoceptors in baroreflex bradycardia. Clin Exp Hypertens A 1986; 8:1063-1079.
9. Goodwin BP, Anderson GF, Barraco RA. Characterization of muscarinic receptors in the rat nucleus tractus solitarius. Neurosci Lett 1995; 191:131-135.
10. Reynolds DJ, Lowenstein PR, Moorman JM, Grahame-Smith DG, Leslie RA. Evidence for cholinergic vagal afferents and vagal presynaptic M1 receptors in the ferret. Neurochem Int 1994; 25:455-464.
11. Wamsley JK, Gehlert DR, Roeske WR, Yamamura HI. Muscarinic antagonist binding site heterogeneity as evidenced by autoradiography after direct labeling with [3H]-QNB and [3H]-pirenzepine. Life Sci 1984; 34:1395-1402.
12. Hassall CJ, Stanford SC, Burnstock G, Buckley NJ. Co-expression of four muscarinic receptor genes by the intrinsic neurons of the rat and guinea-pig heart. Neuroscience 1993; 56:1041-1048.
13. Perez CC, Tobar ID, Jimenez E, Castaneda D, Rivero MB, Concepcion JL,Chiurillo MA, Bonfante-Cabarcas R. Kinetic and molecular evidences that human cardiac muscle express non-M2 muscarinic receptor subtypes that are able to interact themselves. Pharmacol Res 2006; 54:345-355.
14. Hoover DB, Baisden RH, Xi-Moy SX. Localization of muscarinic receptor mRNAs in rat heart and intrinsic cardiac ganglia by in situ hybridization. Circ Res 1994; 75:813-820.
15. Sterin-Borda L, Borda E. Role of neurotransmitter autoantibodies in the pathogenesis of chagasic peripheral dysautonomia. Ann N Y Acad Sci 2000; 917:273-280.
16. Goin JC, Venera G, Biscoglio-Jimenez BM, Sterin-Borda L. Circulating antibodies against nicotinic acetylcholine receptors in chagasic patients. Clin Exp Immunol 1997; 110:219-225.
17. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995; 155:1151-1164.
18. Shevach EM. Regulatory T cells in autoimmunity. Annu Rev Immunol 2000; 18:423-449.
19. Kierszenbaum F, de Diego JL, Fresno M, Sztein MB. Inhibitory effects of the Trypanosoma cruzi membrane glycoprotein AGC10 on the expression of IL2 receptor chains and secretion of cytokines by subpopulations of activated human T lymphocytes. Eur J Immunol. 1999; 29: 1684-1691.
20. Kierszenbaum F. Immunologic deficiency during experimental Chagas' disease (Trypanosoma cruzi infection): role of adherent nonspecific esterase-positive splenic cells. J Immunol 1982; 129: 2202-2205.
21. Girones N, Cuervo H, Fresno M. Trypanosoma cruzi-induced molecular mimicry and Chagas' disease. Curr Top Microbiol Immunol 2005; 296:89-123.
22. Lopes MF, dos Reis GA. Trypanosoma cruzi-induced immunosuppression: blockade of costimulatory T-cell responses in infected hosts due to defective T-cell receptor-CD3 functioning. Infect Immun 1994; 62:1484-1488.
23. Kierszenbaum F. Views on the autoimmunity hypothesis for Chagas disease pathogenesis. FEMS Immunol Med Microbiol 2003; 37: 1-11.
24. Cardillo F, Nomizo A, Mengel J. The role of the thymus in modulating gamma-delta T cell suppressor activity during experimental Trypanosoma cruzi infection. Int Immunol 1998; 10(2):107-116.
25. Guevara AG, Guilvard E, Coutinho Borges M, Cordeiro Da Silva A, Ouaissi A. N-acetylcysteine and glutathione modulates the behaviour of T. cruzi in experimental murine infections. Immunol Lett 2000; 71:79-83.
26. Ikezawa Y, Nakazawa M, Tamura C, Takahashi K, Minami M, Ikezawa Z. Cyclophosphamide decreases the number percentage and the function of CD25+ CD4+ regulatory T cells which suppress induction of contact hypersensitivity. J Dermatol Sci 2005; 39:105-112.
27. Motoyoshi Y, Kaminoda K, Saitoh O, Hamasaki K, Nakao K, Ishii N, Nagayama Y, Eguchi K. Different mechanisms for anti-tumor effects of low- and high-dose cyclophosphamide. Oncol Rep 2006; 16:141-146.
28. L'age-Stehr J, Diamantstein T. Studies on induction and control of cell-mediated autoimmunity. I. Induction of "auto-reactive" T lymphocytes in mice by cyclophosphamide. Eur J Immunol 1978; 8:620-624.
29. Hopkins HA, Betsill WLJr, Hobson AS, Looney WB. Cyclophosphamide-induced cardiomyopathy in the rats. Cancer Treat Rep 1982; 66:1521-1527.
30. Andrade ZA, Andrade SG, Sadigursky M. Enhancement of chronic Trypanosoma cruzi myocarditis in dogs treated with low doses of cyclophosphamide. Am J Pathol 1987; 127:467-473.
31. Bestetti RB, Soares EG, Sales-Neto VN, Oliveira JS. The ajmaline test as a method to disclose latent experimental Chagas' heart disease. Cardiovasc Drugs Ther 1989; 3:171-176.
32. Bestetti RB, Sales-Neto VN, Pinto LZ, Soares EG, Muccillo G, Oliveira JS. Effects of long term metoprolol administration on the electrocardiogram of rats infected with T cruzi. Cardiovasc Res 1990; 24:521-527.
33. Bestetti RB, Pinto LZ, Soares EG, Muccillo G, Oliveira JS. Changes in electrocardiographic patterns at different stages of Chagas' heart disease in rats. Clin Sci (Lond) 1991; 80:33-37.
34. De Souza AP, Tanowitz HB, Chandra M, Shtutin V, Weiss LM, Morris SA, Factor SM, Huang H, Wittner M, Shirani J, Jelicks LA. Effects of early and late verapamil administration on the development of cardiomyopathy in experimental chronic Trypanosoma cruzi (Brazil strain) infection. Parasitol Res 2004; 92:496-501.
35. Mukherjee S, Belbin TJ, Spray DC, Iacobas DA, Weiss LM, Kitsis RN, Wittner M,Jelicks LA, Scherer PE, Ding A, Tanowitz HB. Microarray analysis of changes in gene expression in a murine model of chronic chagasic cardiomyopathy.Parasitol Res 2003; 91:187-196.
36. Saitoh O, Nagayama Y. Regulation of Graves' hyperthyroidism with naturally occurring CD4+CD25+ regulatory T cells in a mouse model. Endocrinology 2006; 147:2417-2422.
37. Cunha-Neto E, Bilate AM, Hyland KV, Fonseca SG, Kalil J, Engman DM. Induction of cardiac autoimmunity in Chagas heart disease: a case for molecular mimicry. Autoimmunity. 2006; 39(1):41-54.
38. Zhang L, Tarleton RL. Parasite persistence correlates with disease severity and localization in chronic Chagas' disease. J Infect Dis 1999; 180:480-486.
39. Tarleton RL, Zhang L. Chagas disease etiology: autoimmunity or parasite persistence? Parasitol Today 1999; 15:94-99.
40. Oliveira JS. A natural human model of intrinsic heart nervous system denervation: Chagas' cardiopathy. Am Heart J 1985; 110:1092-1098.
41. Ribeiro AL, Moraes RS, Ribeiro JP, Ferlin EL, Torres RM, Oliveira E, Rocha MO. Parasympathetic dysautonomia precedes left ventricular systolic dysfunction in Chagas disease. Am Heart J 2001; 141:260-265.
42. Davila DF, Gottberg CF, Donis JH, Torres A, Fuenmayor AJ, Rossell O. Vagal stimulation and heart rate slowing in acute experimental chagasic myocarditis. J Auton Nerv Syst 1988; 25:233-234.
43. Fazan VP, Lachat JJ. Qualitative and quantitative morphology of the vagus nerve in experimental Chagas' disease in rats: a light microscopy study. Am J Trop Med Hyg 1997; 57:672-677.